Deciphera Pharmaceuticals, Inc.
DCPHDelisted Jun 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001654151
Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Deciphera Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 147 | 1 | 145 | −1 |
| Shares | 58.0M | 96.3K | 56.2M | −1.71M (−3.0%) |
| Value | $896.5M | $1.49M | $792.1M | −$103.0M (−11.5%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 370,000 | $5.21M | 0.31% |
| CIBC World Markets Corp | 300,000 | $4.22M | 0.03% |
| HSBC Holdings PLC | 137,610 | $1.94M | 0.00% |
| Qube Research & Technologies Ltd | 101,547 | $1.43M | 0.01% |
| First Trust Advisors LP | 71,501 | $1.01M | 0.00% |
| Alps Advisors Inc | 57,721 | $812.7K | 0.01% |
| Jupiter Asset Management Ltd | 44,139 | $621.0K | 0.01% |
| Adage Capital Partners GP, L.L.C. | 29,661 | $417.6K | 0.00% |
| Verition Fund Management LLC | 18,240 | $256.8K | 0.00% |
| Ergoteles LLC | 16,309 | $229.6K | 0.01% |
| HRT Financial LP | 16,072 | $226.0K | 0.00% |
| Graham Capital Management, L.P. | 15,448 | $217.5K | 0.01% |
| Exchange Traded Concepts, LLC | 9,803 | $138.0K | 0.00% |
| Allworth Financial LP | 1,603 | $22.6K | 0.00% |
| Huntington National Bank | 455 | $6.41K | 0.00% |
Sold out (16)
Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Deep Track Capital, LP | 1,363,201 | $21.1M |
| Woodline Partners LP | 339,905 | $5.25M |
| Citadel Advisors LLC | 146,211 | $2.26M |
| Cubist Systematic Strategies, LLC | 123,486 | $1.91M |
| Wellington Management Group LLP | 79,289 | $1.23M |
| Campbell & CO Investment Adviser LLC | 42,881 | $662.5K |
| TD Asset Management Inc | 41,200 | $636.5K |
| Fox Run Management, L.L.C. | 25,248 | $390.1K |
| Engineers Gate Manager LP | 24,079 | $372.0K |
| Bayesian Capital Management, LP | 22,411 | $346.3K |
| Alyeska Investment Group, L.P. | 20,400 | $315.2K |
| Algert Global LLC | 15,492 | $239.4K |
| Man Group plc | – | $154.7K |
| Lazard Asset Management LLC | 8,421 | $130.0K |
| TCI Wealth Advisors, Inc. | 290 | $4.48K |
| Ellevest, Inc. | 161 | $2.49K |
Not filed for Q2 2023 yet (1)
Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Sunesis Advisors, LLC | 96,299 | $1.49M |